Estrogen, DNA damage and mutations

Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis

Volumn 424, Issue 1-2, 1999, Pages 107-115

  Roy, Deodutta ^a   Liehr, Joachim G ^b  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^b Stehlin Found for Cancer Research   (United States)

Author keywords

Estrogen induced chromosomal aberration; Estrogen induced DNA adduct; Estrogen induced gene mutation; Estrogen induced genome mutation; Estrogen induced hydroxy radical action

Indexed keywords

DIETHYLSTILBESTROL; ESTRADIOL; ESTROGEN; ESTRONE; FREE RADICAL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARCINOGENESIS; CHROMOSOME ABERRATION; COVALENT BOND; DNA ADDUCT; DNA BINDING; DNA DAMAGE; GENE MUTATION; GENOME; GENOTOXICITY; HAMSTER; KIDNEY TUMOR; METABOLIC ACTIVATION; MUTATION; NONHUMAN; PRIORITY JOURNAL; UTERUS CANCER;

ANIMALS; CHROMOSOME ABERRATIONS; CRICETINAE; DNA ADDUCTS; DNA DAMAGE; ESTROGENS; MUTATION;

BACTERIA (MICROORGANISMS); CRICETINAE; MAMMALIA; RODENTIA;

EID: 0033535424     PISSN: 00275107     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0027-5107(99)00012-3     Document Type: Article

References (71)

1. IARC, Monographs on the evaluation of the carcinogenic risk of chemicals to human: sex hormones, Vol. 21, IARC, Lyon, France, 1979, pp. 173-221.
2. R. Hertz, The estrogen problem-retrospect and prospect, in: J.A. McLachlan (Ed.), Estrogens in the Environment: II. Influences on Development, Elsevier, New York, 1985, pp. 1-11.
3. Marselos M., Tomatis L. Diethylstilbestrol: I. Pharmacology, toxicology, and carcinogenicity in humans. Eur. J. Cancer. 28:1992;1182-1189.
4. Liehr J.G. Genotoxic effects of estrogens. Mutat. Res. 238:1990;269-276.
5. Liehr J.G., Roy D. Free radical generation by redox cycling of estrogens. Free Radical Biol. Med. 8:1990;415-423.
6. Barrett J.C., Wong A., McLachlan J.A. Diethylstilbestrol induces neoplastic transformation without measurable gene mutation at two loci. Science. 212:1981;1402-1404.
7. J.J. Li, S.A. Li, Estrogen carcinogenesis in hamster tissues: a critical review, Endocrine Rev. 11 (199) 524-531.
8. S.A. Li, X. Hou, J.J. Li, Estrogen carcinogenesis: A sequential, epigenotoxic, multistage process, in: J.J. Li, S. Nandi, S.A. Li, J. Gustafsson, L. Sekely (Eds.), Hormonal Carcinogenesis, Springer, New York, 1996, pp. 200-208.
9. 32P-postlabelling assay to study transplacental carcinogens and transplacental carcinogenesis, in: N.P. Napalkov, J.M. Rice, L. Tomatis, H. Yamasaki (Eds.), Perinatal and Multigeneration Carcinogenesis, IARC, International Agency for Research on Cancer, Lyon, France, 1989, pp. 189-205.
10. Gladek A., Liehr J.G. Mechanism of genotoxicity of diethylstilbestrol in vivo. J. Biol. Chem. 26:1989;16847-16852.
11. Gladek A., Liehr J.G. Transplacental genotoxicity of diethylstilbestrol. Carcinogenesis. 12:1991;773-776.
12. Jaggi W., Lutz W.K., Schlatter C. Covalent binding of ethinyl estradiol and estrone to rat liver DNA in vitro. Chem. Biol. Interact. 23:1978;13-18.
13. Bolt H.M. Metabolism of estrogens-natural and synthetic. Pharm. Ther. 4:1979;155-181.
14. Williams G.W., Iatropoulos M., Cheung R., Radi L., Wang C.X. Diethylstilbestrol liver carcinogenicity and modifications of DNA in rats. Cancer Lett. 68:1993;193-198.
15. Montandon F., Williams G.M. Comparison of DNA reactivity of the polyphenylethylene hormonal agents diethylstilbestrol, tamoxifen and toremifene in rat and hamster liver. Arch. Toxicol. 68:1994;272-275.
16. Thomas R.D., Roy D. Base sequence specific attack of DES metabolites to mitochondrial genome: implications in the induction of mitochondrial genomic instability in kidney of Syrian hamsters. Fundam. Appl. Toxicol. 36(Suppl.):1997;309.
17. Thomas R.D., Roy D. In vivo mitochondrial genotoxicity of diethylstilbestrol. The Toxicologist. 14:1994;327.
18. Bhat H.K., Han X., Gladek A., Liehr J.G. Regulation of the formation of the major diethylstilbestrol-DNA adduct and some evidence of its structure. Carcinogenesis. 15:1994;2137-2142.
19. Ashburn S.P., Han X., Liehr J.G. Microsomal hydroxylation of 2- and 4-fluoroestradiol to catechol metabolites and their conversion to methyl ethers: catechol estrogens as possible mediators of hormonal carcinogenesis. Mol. Pharmacol. 43:1993;534-541.
20. Stack D.E., Buyn J., Gross M.L., Rogan E.G., Cavalieri E.L. Molecular characteristics of catechol estrogen quinones in reactions with deoxyribonucleosides. Chem. Res. Toxicol. 9:1996;851-859.
21. Cavalieri E.L., Stack D.E., Devanesan P.D., Todorovic R., Dwivedy I., Higginbotham S., Johansson S.L., Patil K.D., Gross M.L., Gooden J.K., Ramanathan R., Cerny R.L., Rogan E.G. Molecular origin of cancer: catechol estrogen 3,4-quinones as endogenous tumors initiators. Proc. Natl. Acad. Sci. USA. 94:1997;10937-10942.
22. 32P-postlabeling in studies of hormonal carcinogenesis, in: D.H. Phillips, M. Castegnaro, H. Bartsch (Eds.), IARC Scientific Publications No. 124, Postlabeling Methods for the Detection of DNA Adducts, Lyon, France, 1993, pp. 149-155.
23. Randerath K., Liehr J.G., Gladek A., Randerath E. Age-dependent covalent DNA alterations (I-compounds) in rodent tissues: species, tissue and sex specificities. Mutat. Res. 219:1989;121-133.
24. Liehr J.G., Randerath K., Randerath E. Target organ-specific covalent DNA damage preceding diethylstilbestrol-induced carcinogenesis. Carcinogenesis. 6:1985;1067-1069.
25. Liehr J.G., Avitts T.A., Randerath E., Randerath K. Estrogen-induced endogenous DNA adduction: possible mechanism of hormonal cancer. Proc. Natl. Acad. Sci. USA. 83:1986;5301-5305.
26. Liehr J.G., Hall E.R., Avitts T.A., Randerath E., E K. Randerath, localization of estrogen-induced DNA adducts and cytochrome P-450 activity at the site of renal carcinogenesis in the hamster kidney. Cancer Res. 47:1987;2156-2159.
27. Liehr J.G., Sirbasku D.A., Jurka E., Randerath K., Randerath E. Inhibition of estrogen-induced renal carcinogenesis in male Syrian hamsters by Tamoxifen without decrease in DNA adduct levels. Cancer Res. 48:1988;779-783.
28. Li D., Wang M.Y., Liehr J.G., Randerath K. DNA adducts induced by lipids and lipid peroxidation products: possible relationships to I-compounds. Mutat. Res. 334(3-4):1995;117-126.
29. Liehr J.G., Ulubelen A.A., Strobel H.W. Cytochrome P-450-mediated redox cycling of estrogens. J. Biol. Chem. 261:1986;16865-16870.
30. Roy D., Liehr J.G. Temporary decrease in renal quinone reductase activity induced by chronic administration of estradiol to male Syrian hamsters. J. Biol. Chem. 263(8):1988;3646-3651.
31. Roy D., Strobel H.W., Liehr J.G. Cytochrome b5-mediated redox cycling of estrogen. Arch. Biochem. Biophys. 285:1991;331-338.
32. Wyllie S., Liehr J.G. Release of iron from ferritin storage by redox cycling of stilbene and steroid estrogen metabolites: a mechanism of induction of free radical damage by estrogen. Arch. Biochem. Biophys. 346:1997;180-186.
33. Kodama M., Inoue F., Kaneko M., Oda T., Sato Y. Formation of free radicals and active oxygen species from diethylstilbestrol and its derivatives. Anticancer Res. 13:1993;1209-1213.
34. Nutter L.M., Wu Y.Y., Ngo E.O., Sierra E.E., Gutierrez P.L., Abul-Hajj Y.J. An o-quinone form of estrogen produces free radicals in human breast cancer cells: correlation with DNA damage. Chem. Res. Toxicol. 7:1994;23-28.
35. 2+. Arch. Biochem. Biophys. 347:1997;45-52.
36. Roy D., Floyd R.A., Liehr J.G. Elevated 8-hydroxydeoxyguanosine levels in DNA of diethylstilbestrol-treated Syrian hamsters: covalent DNA damage by free radicals generated by redox cycling of diethylstilbestrol. Cancer Res. 51:1991;3882-3885.
37. Han X., Liehr J.G. Microsome-mediated 8-hydroxylation of guanine bases of DNA by steroid estrogens: correlation of DNA damage by free radicals with metabolic activation to quinones. Carcinogenesis. 16:1995;2571-2574.
38. Han X., Liehr J.G. 8-Hydroxylation of guanine bases in kidney and liver DNA of hamsters treated with estradiol: role of free radicals in estrogen-induced carcinogenesis. Cancer Res. 54:1994;5515-5517.
39. Roy D., Bernhardt A., Strobel H.W., Liehr J.G. Catalysis of the oxidation of steroid and stilbene estrogens to estrogen quinone metabolites by the α-naphthoflavone-inducible cytochrome P450 IA family. Arch. Biochem. Biophys. 296:1992;450-456.
40. Roy D., Liehr J.G. Target organ-specific inactivation of drug metabolizing enzymes in kidney of hamsters treated with estradiol. Mol. Cell. Biochem. 110:1992;31-39.
41. Wang M.Y., Liehr J.G. Induction by estrogens of lipid peroxidation and lipid peroxide-derived malonaldehyde-DNA adducts in male Syrian hamsters: role of lipid peroxidation in estrogen-induced kidney carcinogenesis. Carcinogenesis. 16:1995;1941-1945.
42. Wang M.-Y., Liehr J.G. Identification of fatty acid hydroperoxide cofactors in the cytochrome P450-mediated oxidation of estrogens to quinone metabolites: role and balance of lipid peroxides during estrogen-induced carcinogenesis. J. Biol. Chem. 269:1994;284-291.
43. Wang M.Y., Liehr J.G. Lipid hydroperoxide-induced endogenous DNA adducts in hamsters: possible mechanism of lipid hydroperoxide-mediated carcinogenesis. Arch. Biochem. Biophys. 316:1995;38-46.
44. 3H ]-hydride reduction J. Biol. Chem. 266:1991;14446-14450.
45. Nutter L.M., Ngo E.O., Abul-Hajj Y.J. Characterization of DNA damage induced by 3,4-estrone-o-quinone. J. Biol. Chem. 226:1991;16380-16386.
46. Han X., Liehr J.G. DNA single strand breaks in kidneys of Syrian hamsters treated with steroidal estrogens, hormone-induced free radical damage preceding renal malignancy. Carcinogenesis. 15:1994;977-1000.
47. Ho S.M., Roy D. Sex hormone-induced increases in DNA strand breakage and lipid peroxidation in the dorsolateral prostate of Noble rats. Cancer Lett. 84:1994;155-164.
48. M. Metzler, E. Pfeiffer, M. Schuler, W. Kohl, R. Schnitzler, Effects of estrogen on microtubule assembly: significance for aneuploidy, in: J.J. Li, S. Nandi, S.A. Li, J. Gustafsson, L. Sekely (Eds.), Hormonal Carcinogenesis. Springer, New York, 1996, pp. 86-93.
49. M. Metzler, E. Pfeiffer, W. Kohl, R. Schnitzler, Interactions of carcinogenic estrogens with microtubular proteins, in: J.J. Li, S. Nandi, S.A. Li (Eds.), Hormonal Carcinogenesis, Springer, New York, 1992, pp. 86-93.
50. Jones L.A., Hajek R.A. Effects of estrogenic chemicals on development. Environ. Health Perspect. 103(7):1995;63-67.
51. Hajek R.A., Pathak S., Boddie A.K., Jones L.A. Aneuploidy of mouse cervicovaginal epithelium induced by perinatal estrogen treatment. Proc. Am. Assoc. Cancer Res. 30:1989;299.
52. Tsutsui T., Maizumi H., McLachlan J.A., Barrett J.C. Aneuploidy induction and cell transformation by DES: a possible chromosomal mechanism in carcinogenesis. Cancer Res. 43:1983;3814-3818.
53. S.H. Banerjee, S. Banerjee, S.A. Li, J.J. Li, Cytogenetic changes in renal neoplasms and during estrogen-induced carcinogenesis, in: J.J. Li, S. Nandi, S.A. Li (Eds.), Hormonal Carcinogenesis, Springer, New York, 1992, pp. 247-251.
54. Aizu-Yokota E., Ichinoseki K., Sato Y. Microtubule disruption induced by estradiol in estrogen receptor-positive and -negative human breast cell lines. Carcinogenesis. 15:1994;1875-1879.
55. E. Pfeiffer, B. Rosenberg, M. Metzler, Bisphenol A disturbs microtubule assembly and induces micronuclei in vitro, in: J.J. Li, S. Nandi, S.A. Li, J. Gustafsson, L. Sekely (Eds.), Hormonal Carcinogenesis, Springer, New York, 1996, pp. 450-453.
56. Paquette B. Enhancement of genomic instability by 17 β-estradiol in minisatellite sequences of X-ray-transformed mouse 10T/2 cells. Carcinogenesis. 17:1996;1221-1225.
57. Boyd J., Takahashi H., Waggoner S.E., Jones L.A., Hajek R.A., Wharton J.T., Liu F.S., Fujino T., McLachlan J.A. Molecular genetics analysis of clear cell adenocarcinomas of the vagina associated and unassociated with diethylstilbestrol exposure in utero. Cancer. 77:1996;507-513.
58. Banerjee S.K., Banerjee S., Li S.A., Li J.J. Induction of chromosome aberrations in Syrian hamster renal cortical cells by various estrogens. Mut. Res. 311:1994;191-197.
59. Endo S., Kodama S., Newbold R.R., McLachlan J., Barrett J.C. Cytogenetic analysis of murine cells from diethylstilbestrol-induced uterine endometrial adenocarcinomas. Cancer Gen. Cytogen. 74:1994;99-103.
60. Metzler M., Pfeiffer E. Effects of estrogens on microtubule polymerization in vitro: correlation with estrogenicity. Environ. Health Perspect. 103(7):1995;21-22.
61. Rudiger H.W., Haenisch F., Metzler M., Oesch F., Glatt H.R. Metabolites of diethylstilbestrol induce sister chromatid exchange in human cultured fibroblasts. Nature. 281:1979;392-394.
62. Liehr J.G., Fang W.F., Sirbasku D.A., Ulubelen A.A. Carcinogenicity of catechol estrogens in Syrian hamsters. J. Steroid Biochem. 24:1986;353-356.
63. Tsutsui T., Suzuki N., Maizumi H., Barrett J.C. Aneuploidy induction in human fibroblasts: comparison with results in Syrian hamster fibroblasts. Mut. Res. 240:1990;241-249.
64. Korah R.M., Humayun M.Z. Mutagenic and recombinogenic effects of diethylstilbestrol quinone. Mut. Res. 289:1993;205-214.
65. Klein C.B. Are diethylstilbestrol and estradiol mutagenic? Proc. Am. Assoc. Cancer Res. 36:1995;259.
66. Rajah T.T., Pento J.T. The mutagenic potential of antiestrogens at the grpt locus in V79 cells. Res. Comm. Mol. Path. Pharmacol. 89:1995;85-92.
67. Roy D., Abul-Hajj Y.J. Estrogen nucleic acid adducts of guanine are a major site of interaction between 3,4-estrone quinone and Co III gene. Carcinogenesis. 18:1997;1247-1249.
68. Yan Z.J., Roy D. Mutations of DNA polymerase β mRNA in stilbene estrogen-induced kidney tumors. Biochem. Mol. Biol. Intl. 37:1995;175-183.
69. Hodgson A.V., Ayala-Torres S., Thompson E.B., Liehr J.G. Estrogen-induced microsatellite DNA alterations are associated with Syrian hamster kidney tumorigeneus. Carcinogenesis. 19:1998;2169-2172.
70. De Benedetti V.M., Welsh J.A., Yu M.C., Bennett W.P. p53 mutations in hepatocellular carcinoma related to oral contraceptive use. Carcinogenesis. 17:1996;145-149.
71. Tsutsui T., Barrett J.C. Neoplastic transformation of cultured mammalian cells by estrogens and estrogen-like chemicals. Env. Health Perspect. 105:1997;619-624. Suppl. 3.